4QDI image
Deposition Date 2014-05-13
Release Date 2015-04-01
Last Version Date 2024-03-20
Entry Detail
PDB ID:
4QDI
Keywords:
Title:
Crystal structure II of MurF from Acinetobacter baumannii
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.25
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
Chain IDs:A
Chain Length:472
Number of Molecules:1
Biological Source:Acinetobacter baumannii
Primary Citation
ATP-binding mode including a carbamoylated lysine and two Mg(2+) ions, and substrate-binding mode in Acinetobacter baumannii MurF
Biochem.Biophys.Res.Commun. 450 1045 1050 (2014)
PMID: 24978312 DOI: 10.1016/j.bbrc.2014.06.108

Abstact

MurF adds d-Ala-d-Ala dipeptide to UDP-N-acetylmuramyl-l-Ala-γ-d-Glu-m-DAP (or l-Lys) in an ATP-dependent manner, which is the last step in the biosynthesis of monomeric precursor of peptidoglycan. Here we report crystal structures of two MurF-ATP complexes: the MurF-ATP complex and the MurF-ATP-UDP complex. The ATP-binding mode revealed by the crystal structure of the MurF-ATP complex confirms the previous biochemical demonstration that a carbamoylated lysine and two Mg(2+) ions are required for enzyme activity of MurF. The UDP-MurF interactions observed in the crystal structure of the MurF-ATP-UDP complex depict the characteristic substrate-binding mode of MurF. The emergence and dissemination of multidrug-resistant Acinetobacter baumannii strains are great threats to public health. Therefore, the structural information on A. baumannii MurF as a validated target for drug discovery will provide a framework to develop antibacterial agents against multidrug-resistant A. baumannii infections as well as to understand the reaction mechanism of MurF.

Legend

Protein

Chemical

Disease

Primary Citation of related structures